One of the cellular mechanisms responsible for generating protein diversity is alternative RNA splicing, producing multiple isoforms from a single gene. Several examples have been described for transcripts encoding proteins involved in cellular signal transduction, including fibroblast growth factor, plateletderived growth factor, epidermal growth factor, nerve growth factor, and insulin receptors and the cytoplasmic kinases Src and Lyn (for a review, see references 3 and 6). Different isoforms generated by alternative splicing have also been described for Met, the hepatocyte growth factor receptor (HGF) (22, 35) . Met is the prototype of a tyrosine kinase receptor family, including the product of avian sea (16) and Ron, the human receptor for the macrophage-stimulating protein (MSP) (13, 36) .
Ron is a heterodimeric protein (p185
RON
) composed of ␣ and ␤ subunits derived from proteolytic cleavage of a common precursor of 170 kDa (13), as previously described for the HGF receptor (14) . p185
RON is expressed in several epithelial tissues, in granulocytes, and in monocytes as the translation product of a 5.0-kb transcript. The extracellular domain of Ron binds the ligand; the membrane-spanning ␤ subunit contains an active tyrosine kinase domain (13) . Other important features common to the products of RON and MET are the major autophosphorylation sites, made of two neighboring tyrosine residues (23) , and a multifunctional docking site located in the receptor tail that mediates signal transduction (32) . Binding of MSP to p185 RON stimulates the intrinsic tyrosine kinase activity and phosphorylation of the docking site recognized by multiple SH2 domain-containing transducer and adapter proteins. This activates the intracellular signaling cascade eliciting a distinctive biological response, shared by Ron and the other members of the MET gene family: cell dissociation, motility, and polarized growth (for a review, see reference 8) .
In this paper, we report constitutive activation of the Ron receptor by intracellular oligomerization of an uncleaved protein isoform lacking 49 amino acids in the extracellular domain (⌬-Ron). This molecule originates from alternative splicing of one cassette exon of 147 bp, because of the presence of a noncanonical splice site consensus sequence. In a gastric carcinoma cell line (KATO-III), the ⌬-RON mRNA is translated into an uncleaved precursor protein (p165
⌬-RON
) containing an uneven number of cysteine residues. Because of aberrant intermolecular disulfide bridge formation, the ⌬-Ron tyrosine kinase oligomerizes in the intracellular compartment and is constitutively activated. This mechanism was mimicked by sitedirected mutagenesis of one cysteine in the Ron extracellular domain. In the mirror experiment, inhibition of thiol-mediated intracellular oligomerization by addition of the reducing agent 2-mercaptoethanol prevented constitutive activation. Interestingly, transfection of ⌬-RON cDNA was followed by the acquisition of an invasive phenotype by recipient cells.
MATERIALS AND METHODS
Cells lines and antibodies. GTL-16 is a clonal cell line derived from a poorly differentiated gastric carcinoma (15) . The other cell lines used, KATO-III (stomach carcinoma), T47D (mammary carcinoma), PT45 (pancreatic carcinoma), MKN-1 (gastric carcinoma), SKOV3 (ovary adenocarcinoma), NIH:OVCAR3 (ovary adenocarcinoma), HOS (bone osteosarcoma), HeLa (cervix carcinoma), COS-1 (simian kidney), and U293 (human kidney), were from the American Type Culture Collection. Cells were grown in RPMI 1640 or in Dulbecco's modified Eagle medium containing 10% fetal calf serum and maintained at 37ЊC in a humidified atmosphere with 5% CO 2 . Phosphotyrosine monoclonal antibodies were from Upstate Biotechnology Inc. (Lake Placid, N.Y.). Ron antibodies were raised as previously described (13) .
Immunoprecipitation and kinase assays. Treatment with reducing agents was performed by growing cells for 2 h in the presence of millimolar concentrations of 2-mercaptoethanol. Monolayers of subconfluent cell cultures were extracted for 20 min at 4ЊC with radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA, 0.1% sodium dodecyl sulfate [SDS], 1% Triton X-100, 1% deoxycholate, 100 M Na 3 VO 4 ) containing pro-tease inhibitors. For nonreducing analysis, 50 mM iodoacetamide was included in the lysis buffer. The cell lysates were cleared by centrifugation at 15,000 ϫ g for 20 min at 4ЊC. Lysates were incubated with Ron antiserum (2.5 l/ml of lysate) coupled to Sepharose-protein A (20 l of packed beads per ml of lysate) for 2 h at 4ЊC with agitation. Sepharose-protein A-bound proteins were washed four times with RIPA buffer and incubated in 50 l of kinase buffer (25 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid [HEPES; pH 7.4], 5 mM MnCl 2 , 0.05% Triton X-100, 5 M leupeptin), supplemented with 40 M ATP and 10 Ci of [␥- 32 P]ATP (specific activity, 5,000 Ci/mmol; Amersham, Little Chalfont, United Kingdom) for 10 min at room temperature. Proteins were separated on SDS-5 to 10% gradient polyacrylamide gels; gels were dried and exposed for autoradiography at Ϫ80ЊC, using intensifying screens. In vivo tyrosine phosphorylation was evaluated by Western blotting (immunoblotting) of the immunoprecipitates with phosphotyrosine antibodies. Subconfluent KATO-III and T47D cells were treated with conditioned medium from U293 cells, either control or MSP transfected, for 10 min at 37ЊC. Cells were lysed in RIPA buffer for immunoprecipitation.
Electroelution of proteins from SDS-gels. Kinase-assayed immunoprecipitates from KATO-III cells were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) (5 to 10% gradient gel) under nonreducing conditions. The labeled high-molecular-weight bands of interest were located by autoradiography, excised from the dried gel, swollen in 20 l of boiling water, mixed with an equal volume of 1ϫ Laemmli buffer, and analyzed by SDS-PAGE in the presence of 2-mercaptoethanol.
Cell surface biotinylation. Cell surface biotinylation was performed by using an ECL (enhanced chemiluminescence) biotinylation kit (Amersham) as instructed by the supplier. After labeling, cells were extracted with ice-cold detergent-insoluble matrix buffer [10 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (PIPES; pH 6.8), 100 mM NaCl, 5 mM MgCl 2 , 300 mM sucrose, 5 mM ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), 1% Triton X-100, protease inhibitors] for immunoprecipitation. Proteins were subjected to SDS-PAGE (7% gel) and Western blotting with streptavidin-horseradish peroxidase and an ECL kit (Amersham).
Northern (RNA) blotting. For Northern analysis, total RNA was extracted as described by Chomczynski and Sacchi (7). Formaldehyde-agarose gel electrophoresis and Northern transfer were performed as described by Wahl et al. (45) . Hybridization was carried out at 65ЊC in Rapid Hyb Buffer (Amersham) in the presence of 10 6 cpm of a [␣-32 P]dCTP oligo-random labeled probe (specific activity, Ͼ10 8 cpm/g of DNA) per ml labeled with the Ready to Go system (Pharmacia, Uppsala, Sweden). The specific probes used were the cDNA encompassing the entire coding sequence of RON and a fragment of 147 bp, corresponding to the region of the receptor deleted in ⌬-RON, obtained by PCR amplification. PCR-amplified fragments shown in Fig. 3B were subjected to 1% agarose gel electrophoresis, transferred to Hybond-Nϩ (Amersham) nylon membranes, and hybridized with the full-length RON cDNA probe by using a Direct nucleic acid labeling system kit (Amersham) as instructed by the supplier.
RT and PCR. Total RNA, extracted with guanidinium thiocyanate as described by Chomczynski and Sacchi (7), was used for reverse transcription (RT). The 40-l reaction mixture contained the enzyme buffer as supplied by Bethesda Research Laboratories, (BRL), 2 g of RNA, 1 U of RNAsin (Promega Biotec, Madison, Wis.) per l, 50 pmol of the 3Ј PCR primer (see below), 1 mM each deoxynucleotide triphosphate, and 10 U of Moloney murine leukemia virus reverse transcriptase (BRL) per l. The reaction mixture was incubated at 37ЊC for 1 h, the enzyme was then denatured for 3 min at 95ЊC, and the products were kept at Ϫ20ЊC. PCR was carried out on the products of the RT reactions as follows. In a final volume of 100 l, the reaction mixture contained 10 l of the products of the RT reaction as source of a template, 50 mM Tris (pH 8.4), 50 mM KCl, 25 g of bovine serum albumin (BRL) per ml, 2 M each deoxynucleotide triphosphate, 35 pmol of the 3Ј PCR primer, 35 pmol of the 5Ј PCR primer, and a variable concentration of MgCl 2 . Five units of Taq polymerase (Promega Biotec) was added, and 100 l of mineral oil was overlaid on the reaction mixture. Thirty cycles of denaturation, annealing, and extension were then performed, using a Programmable Thermal Controller (M.J. Research, Inc.). Denaturation was at 92ЊC for 5 min for the first cycle and for 1 min for subsequent cycles. Annealing temperatures varied between 45 and 63ЊC according to the base composition of the primers; annealing time was 1 min. The extension temperature was 72ЊC. The extension time was calculated by assuming a rate of extension of 1,000 bases/min, according to the predicted length of the amplified product. The oligomers for PCR amplifications used to clone ⌬-RON cDNA were designed on the basis of the RON cDNA sequence as follows: pair 1, sense oligomer corresponding to nucleotides Ϫ183 to Ϫ164 (5Ј-GAGGGCCGGGAA GGGATTTG-3Ј) and antisense oligomer corresponding to nucleotides 393 to 415 (5Ј-TGCTGGTGCTGGATCCCGCGCT-3Ј); pair 2, sense oligomer corresponding to nucleotides Ϫ38 to Ϫ12 (5Ј-CCGGTAGGGATCCTCTAGGGTC CC-3Ј) and antisense oligomer corresponding to nucleotides 2292 to 2315 (5Ј-T GCCCAGGTACCTGGTTCCTGGA-3Ј); pair 3, sense oligomer corresponding to nucleotides 2165 to 2184 (5Ј-ACCAGCCGGGCTGTGCTGGT-3Ј) and antisense oligomer corresponding to nucleotides 3650 to 3672 (5Ј-ACCTGGCTGC GCGGAACTGCAT-3Ј); and pair 4, sense oligomer corresponding to nucleotides 3235 to 3256 (5Ј-GTCAAGGATGTGCTGATTCCC-3Ј) and antisense oligomer corresponding to nucleotides 4366 to 4389 (5Ј-TCTGTGGAGTGAG GTACCTAATG-3Ј).
Sequences encompassing the region of divergence between the cDNA clones isolated from KATO-III cells were amplified on genomic DNA by using two primers flanking this region: sense oligomer corresponding to nucleotides 2619 to 2641 (5Ј-ATCCACCCAGTGCCAACCTAGTT-3Ј) and antisense oligomer corresponding to nucleotides 2873 to 2895 (5Ј-GGCCAGATGGGGTCCCACA GAG-3Ј). One hundred nanograms of genomic DNA was PCR amplified by 20 touchdown cycles (11) with denaturation at 95ЊC for 1 min, annealing temperature decreasing from 64 to 54ЊC for 30 s, extension at 72ЊC for 1 min, and 10 additional cycles at the lowest annealing temperature. The PCR products were subcloned into pUC18 vector and sequenced on both strands.
DNA sequencing. Double-stranded DNA sequencing was carried out by the dideoxynucleotide method (37), using Sequenase (U.S. Biochemicals) and the Sequenase protocol.
Site-directed mutagenesis. The C914A-Ron mutant was created by using a PCR cloning strategy. An antisense primer corresponding to nucleotides 2732 to 2777 (5Ј-GGCAGACAACCATGTCCCCCCGGAACTCGTGCTGGGCGCTC TCACC-3Ј), including a DrdI restriction site for further cloning, was used to mutate Cys-914 to Ala (TGC to GCC), and a sense primer, corresponding to nucleotides 2246 to 2268 (5Ј-CCTGGGGCCACGGTGGCCAGTGT-3Ј), containing an SfiI restriction site was used. The PCR product, double-strand sequenced, was inserted as an SfiI-DrdI cassette in the pMT2*RON vector. The pMT2*C914A/RON cDNA was used for transient expression in COS-1 cells.
Transfection in COS-1 cells. The RON and ⌬-RON cDNAs were inserted into the pMT2* eukaryotic expression vector, which contains the major late adenovirus promoter and the simian virus 40 origin of replication. Subconfluent COS-1 cells were transfected with 10 g of the expression constructs by the DNAcalcium phosphate coprecipitation procedure (CellPhect Transfection kit; Pharmacia) (4). Three days after transfection, expression of the ⌬-Ron and Ron proteins was analyzed by Western blotting.
Transwell migration and invasion assays. Transfected cells were starved for 24 h in serum-free medium before motility and invasion assays were performed, 100 h after transfection. Stimulation of cell invasiveness was determined by using a modification of the Matrigel method (21) . Polycarbonate membranes (8-m pore size) on the bottom of the upper compartment of the Transwells (6.5 mm; Costar Corporation, Cambridge, Mass.) were coated with 1.2 mg of Matrigel (Collaborative Research Incorporated, Waltham, Mass.) per ml. A total of 10 5 transfected cells resuspended in 200 l of serum-free medium were placed on the Matrigel-coated polycarbonate membrane in the upper compartment. One milliliter of medium, either serum free or containing 20 ng of the stimulating factor, was added to the lower compartment. The plates were incubated at 37ЊC in a 5% CO 2 atmosphere saturated with H 2 O for 24 h. At the end of incubation, the cells and Matrigel at the upper side of the polycarbonate filters were mechanically removed. Cells that had invaded the Matrigel and migrated to the lower side of the filter were fixed with 11% glutaraldehyde for 15 min at room temperature, washed three times with distilled water, and stained with 0.1% crystal violet-20% methanol for 20 min at room temperature. After three washes with water and complete drying at room temperature, the crystal violet was solubilized by immersing the filters in 100 l of 10% acetic acid (5 min at room temperature). The concentration of the solubilized crystal violet was evaluated as A 595 .
RESULTS
Detection of a tyrosine-phosphorylated 165-kDa Ron isoform (⌬-Ron) in a gastric carcinoma cell line. Carboxy-terminus-specific antibodies against the Ron receptor (p185 RON ), after immunoprecipitation and Western blotting under reducing conditions identify one single band, with an apparent molecular mass of 150 kDa, corresponding to the ␤ chain. In cells expressing high levels of Ron, the antibodies also identify the pr170 RON precursor as a split double band due to a different extent of glycosylation (13) . In a screening of tumor cells, the Ron antibodies identified a protein with apparent molecular mass of about 165 kDa (⌬-Ron) (Fig. 1) . This abnormal molecule was expressed in the gastric cancer KATO-III cell line and coexisted with the regular 150-kDa Ron ␤ chain, albeit expressed in low quantities.
After specific immunoprecipitation, Western blot experiments with phosphotyrosine antibodies showed that the ⌬-Ron protein was phosphorylated on tyrosine either in the absence or in the presence of the ligand (Fig. 2) . As described before (13) , tyrosine phosphorylation of the Ron ␤ chain is observed only upon MSP stimulation. The Ron ␤ chain was found phosphorylated in KATO-III cells also in the absence of ligand, probably through ⌬-Ron transphosphorylation.
The ⌬-Ron protein originates from an alternatively spliced mRNA. Rearrangements causing aberrant migration and de-VOL. 16, 1996 SPLICING VARIANT OF RON 5519 regulated activity have been reported for the MET gene (30), a RON homolog. To investigate if the ⌬-Ron protein results from a possible genetic damage, the full-length cDNA was cloned from KATO-III cells. RT-PCR was performed to amplify partially overlapping sequences, spanning the entire RON cDNA from position Ϫ183 in the 5Ј untranslated region to position 4242 in the 3Ј untranslated region, using four oligonucleotide primer pairs designed on the basis of the previously reported RON sequence (36) . Several cDNA clones obtained by amplification were sequenced on both strands (Fig. 3A) . of two alleles (encoding a long and a short form of the protein) was ruled out since a single PCR product, corresponding to a size of 442 bp, was obtained from the genomic DNA (Fig. 3B) .
No mutations altering the normal splicing pattern were found in this DNA region; the genomic nucleotide sequence was identical to that of cell lines expressing the wild-type Ron receptor protein (T47D and GTL-16 [data not shown]). These results can be explained only in terms of alternative splicing of a single RON primary transcript. Indeed, a minor cDNA variant lacking 49 amino acids has been described (13) . Two other occurrences of alternative splicing in KATO-III cells have been reported (K-sam and E-cadherin transcripts [19, 29] ).
The relative amounts of ⌬-RON and RON transcripts were then quantitated in Northern analysis by differential hybridization with a full-size RON probe or with a probe corresponding to the 147-bp deleted fragment. The ⌬-RON mRNA was by far the most abundant transcript in KATO-III cells, while the full-size RON transcript was predominant in control cell lines (Fig. 4) . These data show that the gastric cancer cell line studied accumulates the ⌬-RON mRNA that in other cells is a minor component.
The ⌬-RON transcript is missing a 147-bp cassette exon. These data suggest that the two RON transcripts differ in the short 147-bp sequence as a result of a differential maturation of the primary transcript. To verify whether an alternative splicing can occur, the KATO-III genomic PCR amplification product was subcloned in the pUC18 vector and sequenced. Exonintron junctions were identified by comparing genomic and cDNA sequences. This analysis showed that the 147-bp coding sequence is flanked at both 5Ј and 3Ј ends by two short introns of 86 and 80 bp, respectively.
The alternative splicing of the 147-bp sequence occurs through the use of an alternative acceptor site for the 5Ј intron. Its donor site, located at 3Ј end of the preceding exon, can be spliced to two acceptor sites, (i) at bp 2678 and (ii) at bp 2825, located at the origin of the 147-bp sequence and at the origin of the following exon, respectively. In the first case, the spliced intron is of 86 bp and the mature RNA retains the 147-bp miniexon. A donor site at its 3Ј end can be spliced to the acceptor site at position 2825, generating the second 80-bp intron. In the second case, the first donor site is spliced to the alternative acceptor site at bp 2825, consequently generating a long intron that contains the 147-bp cassette exon together with its flanking noncoding sequences (Fig. 3C) . The predicted proteins encoded by the two mRNAs differ by 49 amino acids. Interestingly, among them are three cysteine residues. Thus, the short protein will have an uneven number of free thiol groups, a condition favoring interchain disulfide bond formation and stable oligomerization.
The ⌬-Ron kinase forms oligomers in the intracellular compartment. To characterize the biochemical properties of the protein encoded by ⌬-RON, the corresponding cDNA was expressed in COS-1 cells. As control, cells were also transfected with the RON cDNA. After lysis, proteins were analyzed by specific immunoprecipitation and Western blotting with Ron antibodies. The pattern of migration in reducing conditions of the recombinant ⌬-Ron was found identical to that of the native form identified in the KATO-III cell line (Fig. 5) .
The heterodimeric structure of the wild-type Ron protein was previously deduced from the different migration patterns in reducing and nonreducing conditions (13) . As expected, in an in vitro kinase assay experiment, the shift was observed in the immunoprecipitates obtained from cells expressing the wild-type RON receptor. On the other hand, the p165 ⌬-RON protein migrated to the same extent in reducing and nonreducing conditions. This finding showed that p165 ⌬-RON is a single-chain molecule, with the properties of the pr170 RON precursor, prior to its cleavage (Fig. 6A) . Notably, p165
⌬-RON
, immunoprecipitated either from KATO-III cells or from transfected cells (not shown), was found in oligomers migrating as discrete bands of high molecular weight in nonreducing conditions. The oligomers, excised, reduced, and run again in the presence of 2-mercaptoethanol, were resolved in specific 165-kDa monomers (Fig. 6B VOL. 16, 1996 SPLICING VARIANT OF RON 5521 are formed by ⌬-Ron proteins stabilized by intermolecular disulfide bonds. In principle, it is not possible to exclude that heterodimerization with other proteins could also occur. However, this possibility is reduced to a minimum by the fact that the high-molecular-weight complexes are roughly multiples (in weight) of ⌬-Ron monomer (330 and 660 kDa). The possibility that intermolecular disulfide bonds, hampering ⌬-Ron gel mobility under nonreducing conditions, were postlysis artifacts was ruled out by adding an alkylating agent (iodoacetamide, 50 mM) to the extraction buffer.
The mature, cleaved Ron protein is exposed at the cell surface, as demonstrated by domain-specific surface biotinylation of T47D cells or of cells transfected with the wild-type RON cDNA. In contrast, no biotin-labeled p165 ⌬-RON proteins were immunoprecipitated from KATO-III cells or from COS-1 cells transiently transfected with ⌬-RON cDNA (Fig. 7) . These data show that the deleted ⌬-Ron is retained in the intracellular compartment, possibly in the pre-Golgi vesicular system, as indicated by endoglycosidase-H digestion susceptibility (data not shown).
⌬-Ron oligomers originate by intermolecular disulfide bonding. To confirm that intracellular oligomerization of ⌬-Ron is due to the uneven number of cysteine residues, we generated the mutant C914A-Ron. One of the highly conserved cysteine residues (position 914, included in the 49-amino-acid deletion fragment) was converted to alanine by site-directed mutagenesis. Expression in COS-1 cells of the mutated cDNA was followed by accumulation of the Ron single-chain precursor (pr170
RON
) and retention in the intracellular compartment. The mutant with uneven cysteine residues was constitutively phosphorylated on tyrosine (Fig. 8A) , mimicking that occurring in the ⌬-Ron isoform.
Covalent disulfide bonding is known to be reversible in the presence of reducing agents. Therefore, we added exogenous 2-mercaptoethanol to cells naturally expressing ⌬-Ron (KATO-III) at concentrations not affecting cell viability, terminal glycosylation, or membrane exposure of proteins (1) . Mercaptoethanol allowed maturation of ⌬-Ron, and the correctly processed ␣␤ heterodimer was exposed to the cell surface (Fig. 8B) . The effect of 2-mercaptoethanol was dose dependent, ranging from 2 to 32 mM (maximal activity). Under these conditions, the high-molecular-weight ⌬-Ron aggregates disappeared (data not shown), confirming the central role played by free thiol groups.
⌬-Ron induces cell motility and invasiveness. Under physiological conditions, the Ron receptor transduces mitogenic, motogenic, and invasive signals when stimulated by the growth factor MSP (25) . The ligand-independent tyrosine phosphorylation of ⌬-Ron prompted us to verify if constitutive activation of Ron could be associated with transformation and/or acquisition of an invasive phenotype.
Surprisingly, NIH 3T3 cells transfected by ⌬-RON and expressing the constitutively activated kinase did not form foci of transformation, nor did they grow in soft agar.
A motility assay was then performed to measure the chemotactic and chemokinetic properties of a panel of cells expressing the wild-type Ron or ⌬-Ron. As a control, cells not expressing Ron were studied. Figure 9 shows that the latter were inactive, either in the absence or in the presence of MSP; as expected, the cells expressing wild-type Ron migrated only in the presence of MSP. Interestingly, the cells expressing ⌬-Ron displayed a constitutive motile phenotype. This phenotype was driven either by the endogenous ⌬-Ron, the recombinant ⌬-Ron (cloned from KATO-III cells), or the mutant C914A-Ron, bearing an uneven number of cysteine residues. Notably, the motile-invasive phenotype was expressed constitutively also by NIH 3T3 cells stably transfected with ⌬-Ron and expressing a normal level of protein.
An invasion assay was also performed to assess the ability of ⌬-Ron to drive migration through an artificial basement membrane, made of collagen IV, laminin, and glycosaminoglycans. A kinase assay was performed on immunocomplexes as described in Materials and Methods. Radiolabeled proteins were separated by SDS-PAGE (5 to 10% gradient gel) under reducing (␤ϩ) or nonreducing (␤Ϫ) conditions. Gels were alkali treated, dried, and exposed for autoradiography with intensifying screens. A major tyrosinephosphorylated band of 150 kDa, corresponding to the Ron ␤ chain, was evident. As expected, under nonreducing conditions, the 150-kDa protein, immunoprecipitated from T47D and KATO-III cells, shifted from 150 to 185 kDa because of its association with the ␣ chain. In contrast, the p165 ⌬-RON protein migrated at the same extent both in reducing and nonreducing conditions. The immunocomplexes from KATO-III cells, analyzed by SDS-PAGE in the absence of 2-mercaptoethanol, contained high-molecular-weight oligomers, indicated by the asterisks. The high-molecular-weight bands, excised from the dried gel and reanalyzed under reducing conditions, were resolved in 165-kDa ⌬-Ron monomers (B). Arrows indicate the mature ␣␤ heterodimer (p185 Again, the cells expressing the full-size Ron, either endogenous or transfected, were found to cross the basement membrane only after stimulation with MSP. On the other hand, the cells expressing ⌬-Ron or the C914A-Ron mutant constitutively displayed invasive properties (Fig. 10) .
DISCUSSION
Structural alterations of oncogene-coded proteins can deregulate critical cellular functions. Several examples have been reported for tyrosine kinase receptors, such as the activating rearrangements of TRK, RET, and MET (9, 24, 41) . Moreover 5Ј or 3Ј deletions activate v-erbB (12), v-kit (33), v-fms (47) , and HER2 (5) . The data presented here demonstrate the existence of a structurally altered form of the tyrosine kinase receptor encoded by the RON gene. This isoform (⌬-Ron) is generated by alternative splicing, segregates in the intracellular compartment, oligomerizes by stable intermolecular disulfide bonds, and displays constitutive tyrosine phosphorylation. The cells expressing ⌬-Ron acquire a migratory and invasive phenotype.
⌬-Ron differs from the full-length sequence by lacking 49 amino acids in the extracellular domain. The two transcripts, encoding full-size Ron and the ⌬-Ron isoform, are generated by alternative splicing of a true cassette exon of 147 bp encoding a short segment of the extracellular domain. Cassette exons are nucleotide sequences that may or may not be incorporated into mRNA, but their immediate flanking introns are invariably removed during the splicing process (6) . In the case of the RON mRNA, when the introns flanking the cassette exon are individually removed, the 147 bp are included in the mature transcript; when the flanking introns are removed together, the embodied cassette exon is spliced out and the ⌬-RON mRNA is generated. The second event is due to the existence, at the boundary between the 5Ј intron and the 147-bp cassette exon, of a noncanonical 3Ј splice site consensus sequence (-TA instead of -GT) which can be randomly ignored by the splicing machinery. In general, it has been shown that the selection of a splice site depends not only on its own sequence but also on the context around that sequence (28) . Regarding this point, exons that are intrinsically poor splicing substrates, because of small size or weak flanking splice sites, have been proposed to VOL. 16, 1996 SPLICING VARIANT OF RON 5523 contain positive-acting splicing elements, referred to as exonsplicing enhancers (17, 42, 48) . Canonical exon-splicing enhancer sequences were, however, not easily identifiable in the 147-bp cassette-exon region.
As noted above, most of the known structural defects leading to oncogene activation are due to genetic alterations such as mutations, deletions, or rearrangements. The mechanism leading to the generation of the constitutively tyrosine phosphorylated ⌬-Ron in the cell line studied is posttranscriptional. Posttranscriptional activation has also been observed in the case of the homologous Met/HGF receptor. In a colon carcinoma, accumulation of the uncleaved precursor was responsible for constitutive activation of the intrinsic tyrosine kinase. In this case, however, the precursor accumulation was due to lack of a specific proteolytic enzyme of the trans-Golgi network rather than to an intrinsic structural defect of the protein (26) . The in-frame deletion induces a critical change in the ⌬-Ron structure. Among the missing 49 amino acids are three cysteine residues normally involved in intramolecular disulfide bonds. Therefore, the unbalance of the cysteine pairs renders the uneven cysteines available for intermolecular disulfide bonding with other ⌬-Ron partners, creating oligomers. The existence of high-molecular-weight ⌬-Ron complexes sensitive to reducing agents strongly supports this hypothesis. This situation has already been shown to occur in the case of epidermal growth factor and erythropoietin receptor mutants (40, 46) , and a similar mechanism has been proposed for constitutive activation of the epidermal growth factor, Neu, and fibroblast growth factor receptors (27, 39) . Another example is the germ line mutation, occurring in the multiple endocrine neoplasia 2A (MEN2A) syndrome, that activates RET by replacement of Cys-634; the receptor, containing an uneven number of thiol groups, undergoes steady-state dimerization and constitutive tyrosine kinase activation (38) . Moreover, in the case of the TRK oncogene, a 51-amino-acid deletion in the extracellular domain, removing one cysteine residue, generates a conformation usually achieved by ligand binding (10) . We reproduced biochemical and biological properties of ⌬-Ron by substitution of a single cysteine residue in the extracellular domain. COS-1 cells expressing the C914A-Ron mutant, bearing an uneven number of cysteines, were endowed with deregulated motileinvasive properties, mimicking the phenotype elicited by ⌬-Ron.
The ⌬-Ron molecules oligomerized by interchain cysteine oxidation never reach the cell surface, nor are they correctly processed by proteolytic cleavage. In the Met/HGF receptor, a molecule highly homologous to Ron, a 51-amino-acid deletion variant (with an uneven number of cysteine residues) is not correctly processed and is retained intracellularly (35) . This is somewhat expected, since as a rule, only proteins that have attained the proper three-dimensional structure are secreted or expressed at the cell surface. Folding and assembly intermediates are retained intracellularly. This quality control of newly synthesized molecules takes place notably in the endoplasmic reticulum (18, 20, 31) . For example, it has been shown that the transport of immunoglobulin light chains with exposed thiols is hindered by the formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum (34) . Such interactions may be prevented by altering the intracellular redox potential or by site-directed mutagenesis of one relevant cysteine residue, as demonstrated in the case of secretion of immunoglobulin M assembly intermediates (1) . Similarly, we show here that maturation and cell surface exposure of ⌬-Ron can be restored by addition of 2-mercaptoethanol. This observation indicates that disulfide-interchange reactions are responsible for the intracellular retention of ⌬-Ron in the form of partially assembled intermediates.
Accumulation of the misfolded immature ⌬-Ron protein in the intracellular vesicular compartment and its oligomerization due to aberrant intermolecular disulfide bonds have important consequences on receptor functions. The receptor kinase is constitutively activated, and the downstream motile-invasive program is induced in the absence of exogenous signaling. As observed, the affected cells acquire a phenotype characterized by the ability to migrate through basement membranes in vitro. This property correlates with the metastatic phenotype displayed in vivo by malignant cells (2, 43, 44) . Interestingly, although cells expressing a constitutively activated Ron tyrosine kinase are invasive, they do not form foci of transformation in vitro, nor do they grow in soft agar. This observation strengthens the prominent biological features of the tyrosine kinase receptor subfamily to which Ron belongs, i.e., the control of cell dissociation, motility, and invasion, rather than mere growth.
